Search for: "Walls et al v. Action Resources Inc et al" Results 21 - 40 of 41
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
24 Oct 2023, 9:01 pm by renholding
In our 21F-17 example, it means working with your firm’s human resource and legal functions to make sure that your employment agreements and policies are up-to-date and not in violation of that rule. [read post]
24 Oct 2018, 4:33 pm by Kevin LaCroix
  Given the SEC’s expertise, wherewithal, creativity and specialized resources to prosecute any kind of securities fraud, the SEC, not surprisingly, led the charge. [read post]
12 Sep 2022, 5:39 am by Jack Goldsmith
nodeId=468496&ref_=footer_privacy [https://perma.cc/7L4C-WR5C] (noting eighteen examples of how consumers supply information to Amazon, and noting that as a result of these actions, and that as "a result of those actions, you might supply us with . [read post]
11 Jul 2008, 4:30 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: ACTA continues to be discussed and debated: (Michael Geist), (Intellectual Property Watch), (Public Knowledge),  (Techdirt), (Managing Intellectual Property), (Public Knowledge), (Public Knowledge), (Public Knowledge), Apotex challenge to Acular LS patent barred by res judicata: Roche Palo Alto & Allergan v Apotex:… [read post]
5 Apr 2019, 11:58 am by Arthur F. Coon
City and County of San Francisco (Forest City California Residential Development, Inc., et al., Real Parties in Interest) (2019) ___ Cal.App.5th ___. [read post]
13 Jul 2021, 10:58 am by Simon Lester
                THE ESSENTIAL MEDICINES DEBATE PRIOR TO THE COVID-19 PANDEMIC The TRIPS Agreement has been the subject of intense criticism by some who allege that TRIPS subjects developing countries to the prices charged by pharmaceutical companies for essential medicines, practically denying the most vulnerable citizens of these countries access to potentially lifesaving drugs and preventing access to much cheaper generics… [read post]
7 Jul 2023, 1:03 pm by Ryan Goodman
Andrew Restuccia and Ted Mann, “Jan. 6, 2021: How It Unfolded - A Minute-by-Minute Look,” Wall Street Journal (Feb. 12, 2021) 5. [read post]
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its thinking… [read post]
23 Aug 2008, 1:23 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: DRM for streaming music dies a quiet death: (Electronic Frontier Foundation), (Techdirt) CAFC decides Apotex and Impax infringed AstraZeneca’s Prilosec patents: (Law360), (Patent Prospector), (Patent Docs), (GenericsWeb), CAFC upholds lower court’s decision finding USPTO was within its rights to subject a Cooper patent to… [read post]